中商官网
研究报告
康泰医学（300869）
主要经济指标
| 类别\年份 | 营业收入 （元) |
营业利润 （元) |
利润总额 （元) |
净利润 （元) |
资产总计 （元) |
负债合计 （元) |
股东权益合计 （元) |
| 2013 | 214000000.0000 | 50348500.0000 | 60867600.0000 | 53790200.0000 | 273000000.0000 | 90022900.0000 | 183000000.0000 |
| 2014 | 252000000.0000 | 49453800.0000 | 60289500.0000 | 54461100.0000 | 304000000.0000 | 75082200.0000 | 229000000.0000 |
| 2015 | 284000000.0000 | 58643100.0000 | 71115800.0000 | 61533500.0000 | 423000000.0000 | 130000000.0000 | 293000000.0000 |
| 2016 | 442000000.0000 | 96756700.0000 | 120000000.0000 | 103000000.0000 | 495000000.0000 | 124000000.0000 | 371000000.0000 |
| 2017 | 398000000.0000 | 84592200.0000 | 88055500.0000 | 77057200.0000 | 554000000.0000 | 108000000.0000 | 447000000.0000 |
| 2018 | 363000000.0000 | 69471600.0000 | 69352300.0000 | 62031000.0000 | 575000000.0000 | 66140200.0000 | 509000000.0000 |
| 2019 | 387000000.0000 | 81594400.0000 | 81905000.0000 | 73781200.0000 | 679000000.0000 | 95977300.0000 | 583000000.0000 |
| 2020 | 1401000000.0000 | 715000000.0000 | 715000000.0000 | 613000000.0000 | 2098000000.0000 | 529000000.0000 | 1569000000.0000 |
| 2021 | 909000000.0000 | 406000000.0000 | 408000000.0000 | 352000000.0000 | 2789000000.0000 | 969000000.0000 | 1820000000.0000 |
| 2022 | 712000000.0000 | 219000000.0000 | 219000000.0000 | 196000000.0000 | 3733000000.0000 | 1804000000.0000 | 1928000000.0000 |
| 2023 | 747000000.0000 | 187000000.0000 | 186000000.0000 | 166000000.0000 | 3212000000.0000 | 1167000000.0000 | 2045000000.0000 |
| 2024 | 480000000.0000 | -67550300.0000 | -73887300.0000 | -77902600.0000 | 2726000000.0000 | 868000000.0000 | 1857000000.0000 |
盈利能力分析
| 类别\年份 | 销售毛利率 （%) |
营业利润率 （%) |
总资产利润率 （%) |
净资产收益率 | 存货周转率 | 应收账款周转率 （次) |
总资产周转率 （次) |
| 2013 | 23.36 | 28.44 | 22.30 | 46.9600 | 0.9600 | 22.78 | 0.78 |
| 2014 | 19.44 | 23.92 | 19.83 | -- | 1.2100 | 15.42 | 0.83 |
| 2015 | 20.42 | 25.04 | 16.81 | 22.7400 | 1.0400 | 10.44 | 0.67 |
| 2016 | 21.72 | 27.15 | 24.24 | 29.5400 | 1.5200 | 14.60 | 0.89 |
| 2017 | 17.34 | 22.12 | 15.89 | 18.8500 | 1.5100 | 16.15 | 0.72 |
| 2018 | 16.25 | 19.11 | 12.06 | 12.9800 | 1.5900 | 14.04 | 0.63 |
| 2019 | 18.09 | 21.16 | 12.06 | 14.4900 | 1.7000 | 9.02 | 0.57 |
| 2020 | 48.32 | 51.03 | 34.08 | 62.4300 | 2.8400 | 18.00 | 0.67 |
| 2021 | 42.68 | 44.88 | 14.63 | 20.9000 | 1.3200 | 10.83 | 0.33 |
| 2022 | 21.35 | 30.76 | 5.87 | 10.5400 | 0.8800 | 6.28 | 0.19 |
| 2023 | 18.74 | 24.90 | 5.79 | 8.3600 | 0.7100 | 7.45 | 0.23 |
| 2024 | -20.63 | -15.39 | -2.71 | -4.0200 | 0.6600 | 11.18 | 0.18 |
偿债能力分析
| 类别\年份 | 资产负债率 （%) |
股东权益比率 （%) |
流动比率 | 速动比率 |
| 2013 | 32.98 | 67.03 | 1.7700 | 0.4400 |
| 2014 | 24.70 | 75.33 | 2.6900 | 0.8800 |
| 2015 | 30.73 | 69.27 | 2.3900 | 0.8300 |
| 2016 | 25.05 | 74.95 | 3.2100 | 1.8100 |
| 2017 | 19.49 | 80.69 | 4.5700 | 2.6700 |
| 2018 | 11.50 | 88.52 | 8.5100 | 5.2300 |
| 2019 | 14.14 | 85.86 | 4.7500 | 2.9800 |
| 2020 | 25.21 | 74.79 | 2.4600 | 1.7900 |
| 2021 | 34.74 | 65.26 | 1.4100 | 0.7600 |
| 2022 | 48.33 | 51.65 | 2.3000 | 1.4500 |
| 2023 | 36.33 | 63.67 | 5.4000 | 2.5400 |
| 2024 | 31.84 | 68.12 | 14.2500 | 6.7500 |
成本费用分析
| 类别\年份 | 营业成本 （元) |
销售费用 （元) |
管理费用 （元) |
财务费用 （元) |
| 2013 | 164000000.0000 | 25062200.0000 | 40678700.0000 | 5820300.0000 |
| 2014 | 203000000.0000 | 27463600.0000 | 53263900.0000 | 932100.0000 |
| 2015 | 226000000.0000 | 41821100.0000 | 52169300.0000 | -555300.0000 |
| 2016 | 346000000.0000 | 49331000.0000 | 60678600.0000 | -2143900.0000 |
| 2017 | 329000000.0000 | 52308000.0000 | 23675700.0000 | -2217100.0000 |
| 2018 | 304000000.0000 | 49619400.0000 | 31018400.0000 | -8610100.0000 |
| 2019 | 317000000.0000 | 52761900.0000 | 24767800.0000 | -9680500.0000 |
| 2020 | 724000000.0000 | 61162000.0000 | 33645200.0000 | 2579900.0000 |
| 2021 | 521000000.0000 | 66110200.0000 | 32841200.0000 | -113000000.0000 |
| 2022 | 560000000.0000 | 90212600.0000 | 34435000.0000 | -44605500.0000 |
| 2023 | 607000000.0000 | 118000000.0000 | 41778200.0000 | -4366800.0000 |
| 2024 | 579000000.0000 | 88527000.0000 | 40822200.0000 | -2805000.0000 |